ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Urinary Exosomal Hemopexin, a Validated Diagnostic Marker for Rejection in Kidney Transplant Recipients

J. Lee1, J. Kim2, G. Lee2, S. Jeon2, H. Noh2, J. Lim2, H. Jung2, J. Choi2, J. Cho2, S. Park2, Y. Kim2, C. Kim2

1Internal Medicine, Daegu Fatima Hospital, Daegu, Korea, Republic of, 2Internal Medicine, Kyungpook National University, Daegu, Korea, Republic of

Meeting: 2020 American Transplant Congress

Abstract number: A-312

Keywords: Biopsy, Kidney transplantation, Rejection

Session Information

Session Name: Poster Session A: Biomarkers, Immune Assessment and Clinical Outcomes

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Urinary exosomal hemopexin was identified as a potential diagnostic candidate for kidney allograft rejection in our previous proteomic study. We validated hemopexin as a predictor of acute T cell-mediated rejection (TCMR) as well as chronic active antibody-mediated rejection (CAMR).

*Methods: Urine samples from kidney transplant recipients (KTRs) who underwent graft biopsy were analyzed. There were 98 graft biopsies and we compared the KTRs with stable graft function (STA), TCMR, and CAMR groups. Each patient’s urinary exosome was isolated by exosome isolation kit, and urinary exosomal hemopexin level was measured by ELISA method. To evaluate the discrimination ability, receiver operating characteristic (ROC) analysis was applied.

*Results: Nineteen patients were classified as STA, 18 were TCMR, and 11 were CAMR. The median urinary exosomal hemopexin level was 5.47 (interquartile, 4.30−10.22) ng/mL in STA, 66.87 (28.70−137.95) ng/mL in TCMR, and 162.07 (101.96−221.30) ng/mL in CAMR. Both TCMR and CAMR groups showed significantly higher levels of hemopexin compared to STA group (both P<0.001). In ROC analysis, urinary exosomal hemopexin in TCMR showed an area under curve of 0.90 (95% CI 0.78−1.00) and 0.95 (0.86−1.00) in CAMR.

*Conclusions: Urinary exosomal hemopexin levels were increased in TCMR and CAMR. It could be a potential diagnostic marker for both TCMR and CAMR.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lee J, Kim J, Lee G, Jeon S, Noh H, Lim J, Jung H, Choi J, Cho J, Park S, Kim Y, Kim C. Urinary Exosomal Hemopexin, a Validated Diagnostic Marker for Rejection in Kidney Transplant Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/urinary-exosomal-hemopexin-a-validated-diagnostic-marker-for-rejection-in-kidney-transplant-recipients/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences